|
|
|
Volumn 16 Suppl 2, Issue , 1999, Pages
|
|
Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROSTANE DERIVATIVE;
ANTIASTHMATIC AGENT;
BRONCHODILATING AGENT;
DRUG DERIVATIVE;
FLUTICASONE;
SALBUTAMOL;
SALMETEROL;
ADOLESCENT;
ADULT;
ASTHMA;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
ECONOMICS;
FEMALE;
HUMAN;
MALE;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ADOLESCENT;
ADULT;
ALBUTEROL;
ANDROSTADIENES;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BRONCHODILATOR AGENTS;
COST-BENEFIT ANALYSIS;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
MALE;
MULTICENTER STUDIES;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0033252018
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (43)
|